North America Metered Dose Inhaler Devices Market Outlook to 2023

North America Metered Dose Inhaler Devices Market Outlook to 2023


  • Products Id :- GDMECR0671DB
  • |
  • Pages: 64
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

North America Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalData's new report, "North America Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the North America Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the North America Metered Dose Inhaler Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Metered Dose Inhaler Devices Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 6

3 Metered Dose Inhaler Devices Market, North America 7

3.1 Metered Dose Inhaler Devices Market, North America, Revenue ($m), 2009-2023 7

3.2 Metered Dose Inhaler Devices Market, North America, Revenue ($m), 2009-2016 9

3.3 Metered Dose Inhaler Devices Market, North America, Revenue ($m), 2016-2023 10

3.4 Metered Dose Inhaler Devices Market, North America, Volume (Units), 2009-2023 11

3.5 Metered Dose Inhaler Devices Market, North America, Volume (Units), 2009-2016 13

3.6 Metered Dose Inhaler Devices Market, North America, Volume (Units), 2016-2023 14

3.7 Metered Dose Inhaler Devices Market, North America, Company Share by Revenue ($m), 2016 15

4 Metered Dose Inhaler Devices Market, Canada 17

4.1 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2009-2016 17

4.2 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2016-2023 18

4.3 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2009-2016 19

4.4 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2016-2023 20

4.5 Metered Dose Inhaler Devices Market, Canada, Average Price ($), 2009-2023 21

4.6 Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), 2015-2016 22

4.7 Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), 2016 23

5 Metered Dose Inhaler Devices Market, Mexico 25

5.1 Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), 2009-2016 25

5.2 Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), 2016-2023 26

5.3 Metered Dose Inhaler Devices Market, Mexico, Volume (Units), 2009-2016 27

5.4 Metered Dose Inhaler Devices Market, Mexico, Volume (Units), 2016-2023 28

5.5 Metered Dose Inhaler Devices Market, Mexico, Average Price ($), 2009-2023 29

5.6 Metered Dose Inhaler Devices Market, Mexico, Distribution Share by Revenue ($m), 2015-2016 30

5.7 Metered Dose Inhaler Devices Market, Mexico, Company Share by Revenue ($m), 2016 31

6 Metered Dose Inhaler Devices Market, United States 33

6.1 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2009-2016 33

6.2 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2016-2023 34

6.3 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2009-2016 35

6.4 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2016-2023 36

6.5 Metered Dose Inhaler Devices Market, United States, Average Price ($), 2009-2023 37

6.6 Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 38

6.7 Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), 2016 39

7 Overview of Key Companies in North America Metered Dose Inhaler Devices Market 41

7.1 GlaxoSmithKline Plc 41

7.1.1 Company Overview 41

7.2 AstraZeneca Plc 41

7.2.1 Company Overview 41

7.3 Boehringer Ingelheim GmbH 41

7.3.1 Company Overview 41

7.4 Pfizer Inc 42

7.4.1 Company Overview 42

7.5 Merck & Co Inc 42

7.5.1 Company Overview 42

4.6 Sunovion Pharmaceuticals Inc 42

4.6.1 Company Overview 42

8 Metered Dose Inhaler Devices Market Pipeline Products 43

9 Recent Developments 44

9.1 Corporate Communications 44

9.1.1 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 44

9.1.2 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 44

9.1.3 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 44

9.2 Financial Announcements 45

9.2.1 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 45

9.2.2 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 47

9.2.3 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 49

9.2.4 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics' Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 49

9.2.5 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 52

9.2.6 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 53

9.3 Government and Public Interest 56

9.3.1 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 56

9.4 Other Significant Developments 56

9.4.1 Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 56

9.4.2 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 58

9.5 Strategy And Business Planning 58

9.5.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 58

10 Appendix 60

10.1 Research Methodology 61

10.1.1 Coverage 61

10.1.2 Secondary Research 61

10.1.3 Primary Research 62

10.1.4 Company Share Analysis 62

10.1.5 Distribution Share Analysis 62

10.1.6 Benchmarking 63

10.2 GlobalData Consulting 63

10.3 Contact Us 64

10.4 Disclaimer 64

1.2 List of Figures

Figure 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 7

Figure 2: Metered Dose Inhaler Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 9

Figure 3: Metered Dose Inhaler Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 10

Figure 4: Metered Dose Inhaler Devices Market, North America, Volume (Units), 2009-2023 11

Figure 5: Metered Dose Inhaler Devices Market, North America, Volume (Units), Historic, 2009-2016 13

Figure 6: Metered Dose Inhaler Devices Market, North America, Volume (Units), Forecast, 2016-2023 14

Figure 7: Metered Dose Inhaler Devices Market, North America, Company Share (%) 2016 15

Figure 8: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 9: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Figure 10: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016 19

Figure 11: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023 20

Figure 12: Metered Dose Inhaler Devices Market, Canada, Company Share (%) 2016 23

Figure 13: Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 25

Figure 14: Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 26

Figure 15: Metered Dose Inhaler Devices Market, Mexico, Volume (Units), Historic, 2009-2016 27

Figure 16: Metered Dose Inhaler Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 28

Figure 17: Metered Dose Inhaler Devices Market, Mexico, Company Share (%) 2016 31

Figure 18: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 33

Figure 19: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Figure 20: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 35

Figure 21: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 36

Figure 22: Metered Dose Inhaler Devices Market, United States, Company Share (%) 2016 39

1.1 List of Tables

Table 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 8

Table 2: Metered Dose Inhaler Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 9

Table 3: Metered Dose Inhaler Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 10

Table 4: Metered Dose Inhaler Devices Market, North America, Volume (Units), 2009-2023 12

Table 5: Metered Dose Inhaler Devices Market, North America, Volume (Units), Historic, 2009-2016 13

Table 6: Metered Dose Inhaler Devices Market, North America, Volume (Units), Forecast, 2016-2023 14

Table 7: Metered Dose Inhaler Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2016 16

Table 8: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 17

Table 9: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Table 10: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016 19

Table 11: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023 20

Table 12: Metered Dose Inhaler Devices Market, Canada, Average Price ($), Historic, 2009-2016 21

Table 13: Metered Dose Inhaler Devices Market, Canada, Average Price ($), Forecast, 2016-2023 21

Table 14: Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 22

Table 15: Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 24

Table 16: Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 25

Table 17: Metered Dose Inhaler Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 26

Table 18: Metered Dose Inhaler Devices Market, Mexico, Volume (Units), Historic, 2009-2016 27

Table 19: Metered Dose Inhaler Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 28

Table 20: Metered Dose Inhaler Devices Market, Mexico, Average Price ($), Historic, 2009-2016 29

Table 21: Metered Dose Inhaler Devices Market, Mexico, Average Price ($), Forecast, 2016-2023 29

Table 22: Metered Dose Inhaler Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2015-2016 30

Table 23: Metered Dose Inhaler Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016 32

Table 24: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 33

Table 25: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 26: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 35

Table 27: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 36

Table 28: Metered Dose Inhaler Devices Market, United States, Average Price ($), Historic, 2009-2016 37

Table 29: Metered Dose Inhaler Devices Market, United States, Average Price ($), Forecast, 2016-2023 37

Table 30: Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38

Table 31: Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 40

Table 32: Metered Dose Inhaler Devices Market Pipeline Products 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GlaxoSmithKline Plc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc

Sunovion Pharmaceuticals Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 430921
Site License
USD 11990 INR 861841
Corporate User License
USD 17985 INR 1292762

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com